Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-week, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Valsartan/HCTZ/Amlodipine Compared to Valsartan/HCTZ, Valsartan/Amlodipine, and HCTZ/Amlodipine in Patients With Moderate to Severe Hypertension.

NCT00327587 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00327587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00327587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-week, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Valsartan/HCTZ/Amlodipine Compared to Valsartan/HCTZ, Valsartan/Amlodipine, and HCTZ/Amlodipine in Patients With Moderate to Severe Hypertension.
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
August 31, 2007
Enrollment
2,279 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension